Review By HARMINDER HARMY KAUR Last Updated On : Mar 13 2026 BSc(hons) Pharmacy GPhC Number: 2061107 Authored By GURDEV SEHMI Last Reviewed On : Mar 23 2026 BSc Pharm, MRPharmS, Independent Prescriber, Superintendent Pharmacist, Clinical Lead GPhC Number: 2050925
The well-documented association of postmeal hyperinsulinemia with massive GLP-1 secretion after RYGB [4] raised the possibility that this peptide contributes to enhanced prandial -cell function after this surgery
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management, though some specific formulations are now licensed for weight management in adults with obesity or overweight with weight-related comorbidities
Our side effect comparison guide can help you prepare for that conversation
The reviews, which examine the effects of three weight loss drugs known as GLP-1 receptor agonists, have found that all three drugs result in clinically meaningful weight loss compared with placebo
My heart honestly broke: Why some women feel let down by Serenas GLP-1 promotion Ajla Tomljanovics greatest claim to fame is soon to be wiped